Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PegBio CoHKSE:02565 +23.59%11 EV-to-FCF is -11.95 as of Aug. 08, 2026. GuruFocus rates HKSE:02565 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 341 Biotechnology companies, PegBio Co ranks worse than 293254.84% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PegBio Co's Enterprise Value is HK$2,042.55 Mil.
PegBio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-170.95 Mil. Therefore, PegBio Co's EV-to-FCF for today is -11.95.
The historical rank and industry rank for PegBio Co's EV-to-FCF or its related term are showing as below:
HKSE:02565'
s EV-to-FCF Range Over the Past 10 Years
Min: -11.95 Med: 0 Max: 0
Current: -11.95
HKSE:02565's EV-to-FCF is ranked worse than 100% of 341
companies
in the Biotechnology industry
Industry Median: 15.04
vs HKSE:02565: -11.95
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PegBio Co's share price for today is HK$6.575.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PegBio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.604.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PegBio Co EV-to-FCF Related Terms
PegBio Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for PegBio Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02565 vs VRTX, REGN, RVMD: EV-to-FCF Comparison
For the Biotechnology subindustry, PegBio Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PegBio Co EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PegBio Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where PegBio Co's EV-to-FCF falls into.
PegBio Co's current Enterprise Value is HK$2,042.55 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PegBio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-170.95 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PegBio Co (HKSE:02565) has a EV-to-FCF of -11.95 as of Aug. 08, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PegBio Co and its competitors. According to the industry distribution chart, PegBio Co ranks #999999 out of 341 companies in the Biotechnology industry.
Is PegBio Co's EV-to-FCF too high?
PegBio Co's current EV-to-FCF is -11.95. Based on the distribution chart, PegBio Co ranks #999999 out of 341 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, PegBio Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does PegBio Co's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PegBio Co ranks #999999 out of 341 companies for EV-to-FCF. This places PegBio Co in the lower half of its industry. The industry median EV-to-FCF is 15.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 15.04, based on 341 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PegBio Co and its competitors. For the Biotechnology industry, the median EV-to-FCF is 15.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PegBio Co's current EV-to-FCF is -11.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PegBio Co stock overvalued right now?
PegBio Co (HKSE:02565) has a current EV-to-FCF of -11.95. The current EV-to-FCF is -11.95. PegBio Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For PegBio Co (HKSE:02565), the current EV-to-FCF is -11.95 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PegBio Co Ltd is engaged in the discovery and development of therapies. The company's main product PB-119, is a self-developed, obtained marketing approval from the National Medical Products Administration (NMPA) and entered commercialization preparation stage, long-acting glucagonlike peptide 1 (GLP-1, a peptide hormone that decreases blood sugar levels) receptor agonist. The Company's product candidates include PB-718, PB-1902, PB-722, PB-2301 and PB-2309.
11GF Score
Get the complete analysis for HKSE:02565
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02565 has been successfully added to your 
